Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 21, 2011
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VIIB Sørensen, Y Dargaud, G Kenet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 12, 2016
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFcE Berntorp, C Negrier, P Gozzi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2009
Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiencyJ L Plantier, V Rolli, C Ducasse, et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2011
Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia AM Ninivaggi, Y Dargaud, R van Oerle, et al.
Thrombosis Journal|April 12, 2018
Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiencyS Le Quellec, A Desjonqueres, L Rugeri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2012
The potential role of synovial thrombomodulin in the pathophysiology of joint bleeds in haemophiliaY Dargaud, H Simpson, Y Chevalier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 9, 2012
Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational studyC Rothschild, R D'Oiron, A Borel-Derlon, et al.
Pageof 8